Cart (0 Items)
Your cart is currently empty.
View ProductsVadastuximab Biosimilar – Anti-CD33, SIGLEC3 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Vadastuximab Biosimilar - Anti-CD33, SIGLEC3 mAb - Research Grade |
|---|---|
| Source | CAS 1436390-63-4 |
| Species | Chimeric |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Vadastuximab,h2H12ec,CD33, SIGLEC3,anti-CD33, SIGLEC3 |
| Reference | PX-TA1420 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Vadastuximab Biosimilar - Anti-CD33, SIGLEC3 mAb - Research Grade
General information on Anti-CD33/SIGLEC3[Homo sapiens] (Vadastuximab) Monoclonal Antibody
Vadastuximab has been investigated for the treatment of Acute myeloid leukemia, Myelodysplastic Syndrome, Acute Myelogenous Leukemia, and Acute Promyelocytic Leukemia.
Related products
Antigen
CD331 Recombinant Protein
PX-P4119 310€
Antigen
Myeloid cell surface antigen CD33(CD33)
PX-P4861 210€
Antigen
Sialic acid-binding Ig-like lectin 15(SIGLEC15)
PX-P4693 210€
Antigen
CD333 / FGFR3, C-His, recombinant protein
PX-P5614 385€
SIL
Reviews
Il n’y a pas encore d’avis.